Clinical Trial: Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Study Type: OBSERVATIONAL
Official Title: Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Brief Summary:
This study will examine the clinical effectiveness of Tafamidis in patients with Mixed Phenotype Transthyretin Amyloidosis using data that already exist in patients' medical records
Read more